Yeah,whatever. I'm merely making the point that rash share price predictions generally end up with egg all over your face. I actually wasn't having a go at you, simply stating my view
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025